HB 1461 — Maryland
Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions
Altering the circumstances under which certain insurers, nonprofit health service plans, and health maintenance organizations are prohibited from excluding coverage for certain specialty drugs for the treatment of rheumatologic conditions.
Latest action: Hearing 3/13 at 1:30 p.m. · Mar 13, 2026
Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.
Committees: Health (House of Delegates)
Updated Mar 17, 2026
Timeline
First Reading Health
Feb 13, 2026 · House of Delegates
Hearing 3/13 at 1:00 p.m.
Feb 13, 2026 · House of Delegates
Hearing canceled
Mar 13, 2026 · House of Delegates
Hearing 3/13 at 3:00 p.m.
Mar 13, 2026 · House of Delegates
Hearing canceled
Mar 13, 2026 · House of Delegates
Hearing 3/13 at 1:30 p.m.
Mar 13, 2026 · House of Delegates
Sponsored by Deni Taveras, Mary Lehman, Nicole Williams
No recorded floor votes yet.
Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 27, 2026 (partial import — not yet the full session). Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.